Bicuspid aortic valveCoarctation of the aortaLifelong follow-upTranscatheter therapyVentricular septal defect
Figures from the paper
Abstract (AI)
Coarctation of the aorta occurs in 0.04% of the population, and accounts for approximately 10% of lesions in adults with congenital heart disease. It can occur as an isolated lesion or as a part of a complex defect, and is most commonly associated with bicuspid aortic valve, ventricular septal defect, and mitral valve abnormalities. Since the first surgical repair in 1944, the available treatment options have expanded greatly. Perhaps one of the most important advances in the management of coarctation of the aorta has been the development of transcatheter therapy for both native and especially recurrent coarctation of the aorta. Late complications, even after apparently successful treatment, are not uncommon. For this reason, lifelong follow-up is vital.
Key Findings
1
Coarctation can present as an isolated lesion or with complex defects, most commonly associated with bicuspid aortic valve, ventricular septal defect, and mitral valve abnormalities.
2
Coarctation of the aorta has a prevalence of 0.04% and represents about 10% of lesions in adults with congenital heart disease.
3
Late complications after apparently successful treatment of coarctation are not uncommon, necessitating lifelong follow-up.
4
Treatment options for coarctation have expanded substantially since the first surgical repair in 1944, including important advances in transcatheter therapy for native and recurrent coarctation.
Research Object
Coarctation of the aorta (congenital aortic narrowing)
Research Subject
Clinical epidemiology, associated cardiac anomalies, treatment options including surgical and transcatheter therapies, long-term complications and need for lifelong follow-up in patients with coarctation of the aorta
Publication Details
Publication Date
2020-02-07
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest